Stock Rich List
Nasdaq: RAPP

Rapport Therapeutics insiders

The officers, directors and 10% owners of Rapport Therapeutics, Inc. who hold the most stock, valued at the live RAPP price.

$23.59
RAPP today +$190K (+0.81%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
6
Their RAPP stock
$341M
Market value
$1.40B
Held by ranked insiders
24.4%

Insiders by value of RAPP holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Third Rock Ventures V, L.P.Director6,518,620$154M11.0%Corporate
2Third Rock Ventures VI, L.P.10% owner6,432,715$152M10.9%Corporate
3Steven M. PaulDirector555,022$13.1M0.94%3876th
4Abraham CeesayChief Executive Officer552,493$13.0M0.93%6746th
5David BredtChief Scientific Officer393,075$9.3M0.66%9296th
6John MaraganoreDirector9,411$222K<0.1%1983rd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Rapport Therapeutics; see each profile for the filing.